Trials / Unknown
UnknownNCT04302519
Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- CAR-T (Shanghai) Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of novel coronavirus induced severe pneumonia by dental pulp mesenchymal stem cells
Detailed description
Open, single center, single arm test design. Plan to enroll 24 subjects. On the basis of clinical standard treatment, the injection of dental mesenchymal stem cells was increased on day 1, 3 and 7 of the trial. Injection dose: 1.0x106 cells /kg. Injection method: slowly and quietly drop 50 mL of normal saline, then the endodontic mesenchymal stem cell injection (after 60 min), and then 50 mL of normal saline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Dental pulp mesenchymal stem cells | On the basis of clinical standard treatment, the injection of dental mesenchymal stem cells was increased on day 1, 3 and 7 of the trial. |
Timeline
- Start date
- 2020-03-05
- Primary completion
- 2021-06-30
- Completion
- 2021-07-30
- First posted
- 2020-03-10
- Last updated
- 2020-03-10
Source: ClinicalTrials.gov record NCT04302519. Inclusion in this directory is not an endorsement.